Filing Details

Accession Number:
0001127602-24-021385
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-01 17:06:42
Reporting Period:
2024-07-31
Accepted Time:
2024-08-01 17:06:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
97745 Thermo Fisher Scientific Inc. TMO Measuring & Controlling Devices, Nec (3829) 042209186
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216055 N Marc Casper 168 Third Avenue
Waltham MA 02451
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-07-31 10,000 $210.68 133,816 No 4 M Direct
Common Stock Disposition 2024-07-31 294 $612.55 133,522 No 4 S Direct
Common Stock Disposition 2024-07-31 1,552 $613.52 131,970 No 4 S Direct
Common Stock Disposition 2024-07-31 1,036 $614.87 130,934 No 4 S Direct
Common Stock Disposition 2024-07-31 945 $615.81 129,989 No 4 S Direct
Common Stock Disposition 2024-07-31 670 $617.06 129,319 No 4 S Direct
Common Stock Disposition 2024-07-31 1,790 $618.18 127,529 No 4 S Direct
Common Stock Disposition 2024-07-31 2,497 $619.48 125,032 No 4 S Direct
Common Stock Disposition 2024-07-31 1,216 $620.12 123,816 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-07-31 10,000 $0.00 10,000 $210.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
65,850 2025-02-27 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 11,300 Indirect By Alison Casper 2020 Irrevocable Trust
Common Stock 43,608 Indirect By Floral Park Associates, Inc.
Common Stock 5,000 Indirect By MNC 2020 Irrevocable Trust
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $612.40 to $612.85, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8) and (9) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $613.07 to $613.98, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $614.21 to $615.17, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $615.43 to $616.20, inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $616.69 to $617.65, inclusive.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $617.84 to $618.79, inclusive.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $618.84 to $619.78, inclusive.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $619.88 to $620.24, inclusive.
  10. The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
  11. The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
  12. The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022.